首页 | 本学科首页   官方微博 | 高级检索  
检索        

美、法两国药物警戒机构设置的特点分析及对我国的启示
引用本文:马爱霞,吴抒艺,王越,徐厚明.美、法两国药物警戒机构设置的特点分析及对我国的启示[J].中国药物警戒,2007,4(4):207-211.
作者姓名:马爱霞  吴抒艺  王越  徐厚明
作者单位:1. 中国药科大学国际医药商学院,江苏,南京,210009
2. 江苏省药品不良反应监测中心,江苏,南京,210002
摘    要:目的为我国药物警戒体系的机构设置提供建议。方法对美、法两国药物警戒机构设置的特点进行研究与比较。结果美国与法国的药物警戒机构设置分别属于中央系统和地方系统,两种系统虽然各有其优点与缺陷,但都有值得我国学习和借鉴之处。结论我国建立药物警戒体系需要在组织机构、交流沟通、经费来源及信息技术等方面加以完善与改进。

关 键 词:美国  法国  药物警戒体系  机构设置  启示
文章编号:1672-8629(2007)04-0207-05
修稿时间:2007-03-27

Analysis of organizations of American and French pharmacovigilance systems and suggestions for our system
MA Ai-xia,WU Shu-yi,WANG Yue,XU Hou-ming.Analysis of organizations of American and French pharmacovigilance systems and suggestions for our system[J].Chinese JOurnal of Pharmacovigilance,2007,4(4):207-211.
Authors:MA Ai-xia  WU Shu-yi  WANG Yue  XU Hou-ming
Institution:1 International Pharmaceutical Business School of CPU(Jiangsu NanJing 210009,China;Jiangsu NanJing 210002,China
Abstract:Objective To provide some suggestions for the set-up organization of our pharmacovigi-lance(PV) system. Method Do analysis and comparison on the organizations of American and French PV systems. Result The American and French systems both have their own fortes that we can learn from. Conclusion Our present ADR monitoring system needs to be improved in organization,com-munication,information and financial management.
Keywords:Pharmacovigilance  Organization
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号